JP2023511908A5 - - Google Patents

Info

Publication number
JP2023511908A5
JP2023511908A5 JP2022544353A JP2022544353A JP2023511908A5 JP 2023511908 A5 JP2023511908 A5 JP 2023511908A5 JP 2022544353 A JP2022544353 A JP 2022544353A JP 2022544353 A JP2022544353 A JP 2022544353A JP 2023511908 A5 JP2023511908 A5 JP 2023511908A5
Authority
JP
Japan
Prior art keywords
fusion protein
nucleic acid
cells
acid construct
recombinant virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022544353A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023511908A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/014780 external-priority patent/WO2021151012A1/en
Publication of JP2023511908A publication Critical patent/JP2023511908A/ja
Publication of JP2023511908A5 publication Critical patent/JP2023511908A5/ja
Ceased legal-status Critical Current

Links

JP2022544353A 2020-01-22 2021-01-22 タウ発現抑制のためのジンクフィンガータンパク質転写因子 Ceased JP2023511908A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062964501P 2020-01-22 2020-01-22
US62/964,501 2020-01-22
PCT/US2021/014780 WO2021151012A1 (en) 2020-01-22 2021-01-22 Zinc finger protein transcription factors for repressing tau expression

Publications (2)

Publication Number Publication Date
JP2023511908A JP2023511908A (ja) 2023-03-23
JP2023511908A5 true JP2023511908A5 (enExample) 2024-02-09

Family

ID=74661487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022544353A Ceased JP2023511908A (ja) 2020-01-22 2021-01-22 タウ発現抑制のためのジンクフィンガータンパク質転写因子

Country Status (14)

Country Link
US (1) US20230242602A1 (enExample)
EP (1) EP4093754A1 (enExample)
JP (1) JP2023511908A (enExample)
KR (1) KR20220131273A (enExample)
CN (1) CN115210251A (enExample)
AR (1) AR121118A1 (enExample)
AU (1) AU2021209699A1 (enExample)
BR (1) BR112022014160A2 (enExample)
CA (1) CA3168805A1 (enExample)
IL (1) IL294535A (enExample)
MX (1) MX2022008953A (enExample)
TW (1) TW202134288A (enExample)
UY (1) UY39036A (enExample)
WO (1) WO2021151012A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110214184B (zh) 2016-12-01 2024-07-02 桑格摩生物治疗股份有限公司 τ蛋白调节剂以及用于其递送的方法和组合物
IL326834A (en) 2018-10-02 2026-04-01 Sangamo Therapeutics Inc Artificial zinc finger protein transcription factors repressing mapt expression for the prevention and/or treatment of tauopathies
WO2021067871A1 (en) * 2019-10-02 2021-04-08 Sangamo Therapeutics, Inc. Zinc finger protein transcription factors for repressing alpha-synuclein expression
WO2025193848A1 (en) * 2024-03-13 2025-09-18 Sangamo Therapeutics, Inc. Delivery of tau repressors using the blood-brain barrier penetrant capsid

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
JP4012243B2 (ja) 1994-01-18 2007-11-21 ザ スクリップス リサーチ インスティチュート 亜鉛フィンガータンパク質誘導体およびそのための方法
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
CA2196419C (en) 1994-08-20 2007-08-21 Yen Choo Improvements in or relating to binding proteins for recognition of dna
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
WO2001053480A1 (en) 2000-01-24 2001-07-26 Sangamo Biosciences, Inc. Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
CA2725773C (en) 2008-05-28 2017-12-05 Sangamo Biosciences, Inc. Compositions for linking dna-binding domains and cleavage domains
EP2566972B1 (en) 2010-05-03 2020-01-15 Sangamo Therapeutics, Inc. Compositions for linking zinc finger modules
CA2920899C (en) 2013-08-28 2023-02-28 Sangamo Biosciences, Inc. Compositions for linking dna-binding domains and cleavage domains
EP3929279A1 (en) 2014-03-18 2021-12-29 Sangamo Therapeutics, Inc. Methods and compositions for regulation of zinc finger protein expression
WO2017011556A1 (en) * 2015-07-13 2017-01-19 The General Hospital Corporation Rare phosphorylated high molecular weight (hmw) tau species that are involved in neuronal uptake and propagation and applications thereof
JP7012650B2 (ja) 2016-02-02 2022-01-28 サンガモ セラピューティクス, インコーポレイテッド Dna結合ドメインと切断ドメインとを連結するための組成物
IL264792B2 (en) 2016-08-24 2023-10-01 Sangamo Therapeutics Inc Engineered target-specific zinc-finger nucleases
CN110214184B (zh) * 2016-12-01 2024-07-02 桑格摩生物治疗股份有限公司 τ蛋白调节剂以及用于其递送的方法和组合物
KR20210069692A (ko) 2018-10-02 2021-06-11 상가모 테라퓨틱스, 인코포레이티드 조작된 유전자 조정제
IL326834A (en) 2018-10-02 2026-04-01 Sangamo Therapeutics Inc Artificial zinc finger protein transcription factors repressing mapt expression for the prevention and/or treatment of tauopathies

Similar Documents

Publication Publication Date Title
US9890394B2 (en) Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
WO2009052737A1 (en) Medicament for preventing and controlling alzheimer's disease
JP2018531926A (ja) 神経学的障害を処置するための組成物および方法
IL320371A (en) Gene therapy for patients with fanconi anemia
RU2019126509A (ru) Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
JP2019524090A5 (enExample)
US20190071486A1 (en) Method and composition for treating neuronal hyper-excitability
US20230242602A1 (en) Zinc finger protein transcription factors for repressing tau expression
EP4161953A1 (en) Compositions and methods for the treatment of synucleinopathies
CN109206503A (zh) 一种蛋白用于制备防治阿尔茨海默病药物的用途
US20220098254A1 (en) NEUROD1 and DLX2 VECTOR
JP2022551286A5 (enExample)
JP7680072B2 (ja) リプログラミング用機能性断片、組み合わせ、およびその用途
CN116218849A (zh) 针对utrophin激活治疗杜氏肌营养不良的sgRNA和应用
CN115702246A (zh) 调节性核酸序列
CN121221803A (zh) 胰岛素基因疗法
US20250295717A1 (en) Reprogrammed functional fragment of recombinant oncolytic virus, combination, and application thereof
KR20220071248A (ko) 알파-시누클레인 발현을 억제시키기 위한 아연 핑거 단백질 전사 인자
CN111093716B (zh) 用于治疗神经性疼痛的方法和组合物
CN116286837B (zh) 编码人核因子e2相关因子2的核酸分子、表达载体及其应用
CN117660370B (zh) 一种重组腺相关病毒、抗炎药物及其在脓毒性脑病治疗中的应用
US20240279679A1 (en) Compositions and methods for treatment of spinal muscular atrophy
KR20250097002A (ko) Oct4, Sox2, Klf4 단백질을 포함하는 엔지니어링된 바이러스-유사 입자를 유효성분으로 포함하는 노화의 예방 또는 치료용 약제학적 조성물
CN107296814A (zh) 小分子核苷酸在制备脑损伤的脑保护和脑修复药物中的用途
IL321782A (en) Retro-aav and use in treating neurodegenerative diseases